AMEDISYS INC (AMED) Stock Overview
NASDAQ:AMED - US0234361089 - Common Stock
AMED Key Statistics, Chart & Performance
The current stock price of AMED is 100.99 USD. In the past month the price increased by 3.61%. In the past year, price increased by 2.68%.
AMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.47 | 92.26B | ||
| CI | THE CIGNA GROUP | 10.75 | 80.60B | ||
| LH | LABCORP HOLDINGS INC | 18.35 | 23.08B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.26 | 20.37B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.55 | 15.03B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 111.34 | 14.60B | ||
| DVA | DAVITA INC | 14.2 | 9.84B | ||
| HIMS | HIMS & HERS HEALTH INC | 53.93 | 9.75B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.38B | ||
| CHE | CHEMED CORP | 20.52 | 6.69B | ||
| RDNT | RADNET INC | 198.39 | 5.49B | ||
| OPCH | OPTION CARE HEALTH INC | 21.07 | 4.62B |
Related stock screener links
About AMED
Company Profile
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The company provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. The company owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.
Company Info
AMEDISYS INC
3854 American Way, Suite A
Baton Rouge LOUISIANA 70816 US
CEO: Paul B. Kusserow
Employees: 19000
Phone: 12252922031
AMEDISYS INC / AMED FAQ
What is the stock price of AMEDISYS INC today?
The current stock price of AMED is 100.99 USD. The price increased by 0.01% in the last trading session.
What is the ticker symbol for AMEDISYS INC stock?
The exchange symbol of AMEDISYS INC is AMED and it is listed on the Nasdaq exchange.
On which exchange is AMED stock listed?
AMED stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AMEDISYS INC stock?
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99. Check the AMEDISYS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMEDISYS INC worth?
AMEDISYS INC (AMED) has a market capitalization of 3.32B USD. This makes AMED a Mid Cap stock.
How many employees does AMEDISYS INC have?
AMEDISYS INC (AMED) currently has 19000 employees.
What are the support and resistance levels for AMEDISYS INC (AMED) stock?
AMEDISYS INC (AMED) has a support level at 100.13 and a resistance level at 101. Check the full technical report for a detailed analysis of AMED support and resistance levels.
Is AMEDISYS INC (AMED) expected to grow?
The Revenue of AMEDISYS INC (AMED) is expected to grow by 4.17% in the next year. Check the estimates tab for more information on the AMED EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AMEDISYS INC (AMED) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMED, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMED, evaluating the profitability, health, valuation and growth aspects
- AMEDISYS INC (AMED) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMEDISYS INC (AMED) Sales and EPS estimates to see what analysts future expectations are.
- AMEDISYS INC (AMED) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMEDISYS INC (AMED) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMEDISYS INC (AMED) Stock Chart to make your own analysis
- AMEDISYS INC (AMED) Latest news and press-releases to stay up to date.
Does AMEDISYS INC (AMED) stock pay dividends?
AMED does not pay a dividend.
When does AMEDISYS INC (AMED) report earnings?
AMEDISYS INC (AMED) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of AMEDISYS INC (AMED)?
The PE ratio for AMEDISYS INC (AMED) is 21.26. This is based on the reported non-GAAP earnings per share of 4.75 and the current share price of 100.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMED.
What is the Short Interest ratio of AMEDISYS INC (AMED) stock?
The outstanding short interest for AMEDISYS INC (AMED) is 9.94% of its float. Check the ownership tab for more information on the AMED short interest.
AMED Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AMED. When comparing the yearly performance of all stocks, AMED turns out to be only a medium performer in the overall market: it outperformed 48.13% of all stocks.
AMED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AMED. AMED has an excellent profitability rating, but there are some minor concerns on its financial health.
AMED Financial Highlights
Over the last trailing twelve months AMED reported a non-GAAP Earnings per Share(EPS) of 4.75. The EPS increased by 11.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.56% | ||
| ROA | 3.87% | ||
| ROE | 6.95% | ||
| Debt/Equity | 0.26 |
AMED Forecast & Estimates
17 analysts have analysed AMED and the average price target is 102.87 USD. This implies a price increase of 1.87% is expected in the next year compared to the current price of 100.99.
For the next year, analysts expect an EPS growth of 13.17% and a revenue growth 4.17% for AMED